Dr. Deligiannidis completed her undergraduate degrees in Biology and Psychology at the University of Massachusetts at Amherst. As a recipient of pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the National Institutes of Health (NIH). Dr. Deligiannidis completed additional research training at the NIH during medical school and residency in behavioral endocrinology and experimental therapeutics at the National Institute of Mental Health (NIMH). She received her medical degree from, and completed her psychiatry residency and chief residency in psychopharmacology research at the University of Massachusetts Medical School. After residency she completed a visiting fellowship and further training in multimodal neuroimaging at the Massachusetts General Hospital/Martinos Center for Biomedical Imaging.
Dr. Deligiannidis joined faculty at Zucker Hillside Hospital/Feinstein Institutes for Medical Research/Zucker School of Medicine at Hofstra/Northwell in September 2016 and is Board Certified by the American Board of Psychiatry and Neurology. Dr. Deligiannidis is the Director of Women's Behavioral Health at Zucker Hillside Hospital at Northwell Health. As a reproductive psychiatrist, she has expertise in treating women with mood and anxiety disorders linked to the menstrual cycle and pregnancy/postpartum periods.
Over the past ten years, Dr. Deligiannidis has been a leader in the field of perinatal depression and in novel therapeutics research. Her research program includes a focus in psychoneuroendocrinology, particularly neurosteroids and hormones, and neuroimaging in women's behavioral health. She has authored over 50 peer-reviewed articles plus several textbook chapters, has given over 70 oral presentations and presented over 100 research posters at scientific conferences. Dr. Deligiannidis has received federal, foundation and industry research funding, including prestigious NIH K23 and R01 grants. Her research efforts have been nationally recognized with many awards for research and for teaching of medical students and residents. Her research has been covered by major media outlets, including CNN, the Associated Press, National Public Radio, Boston Globe, Boston ABC News, Boston CBS News, CBS-New York, ABC-New York, Newsday and others.
Dr. Deligiannidis actively contributes to national scientific committees and gives scientific presentations nationally and internationally. She is an Associate Member of the American College of Neuropsychopharmacology (ACNP), a member of the Society of Biological Psychiatry (SOBP), the American Society of Clinical Psychopharmacology (ASCP) and the Marcé Society of North America (perinatal mental health). She serves on the national ASCP Board of Directors, and the SOBP Council, as a reviewer on over 20 scientific journals and on the Advisory Board for the journal Acta Psychiatrica Scandinavica. She also serves as a member of the ACNP Committee on Education & Training and actively serves as a federal grant reviewer for the Center for Scientific Review at NIH.
Locally in metro NYC/Long Island, she serves on steering committees in both the Departments of Obstetrics & Gynecology and Psychiatry at Long Island Jewish Medical Center and Zucker Hillside Hospital and at the Katz Institute for Women's Health on Long Island. She additionally serves on Faculty Council at the Zucker School of Medicine at Hofstra/Northwell. She is a sought-out educator and mentor to medical students, nurse practitioner students, residents, fellows and faculty across Northwell Health and at its Schools of Medicine and Nursing. She serves on Faculty Council at the Zucker School of Medicine at Hofstra/Northwell.